Investor directory

3one4 Capital

3one4 Capital, established in 2016, is an early-stage venture capital firm headquartered in Bangalore, India. The firm focuses on technology-driven companies, investing in sectors such as SaaS, fintech, consumer internet, digital health, and enterprise & SMB automation. With a deep involvement strategy, 3one4 works closely with founding teams to achieve product-market fit and optimize growth. The firm manages a corpus of over INR 3,710 Cr (USD 510M+) and has invested in over 80 companies, including Licious, Darwinbox, and Open. 3one4's investments span India and the United States, with a bias towards companies leveraging technology to create or dominate large markets.
http://3one4capital.com
https://angel.co/company/3one4-capital
https://crunchbase.com/organization/3one4
https://facebook.com/3one4capital
https://linkedin.com/company/3one4-capital
https://pitchbook.com/profiles/investor/154351-72
https://signal.nfx.com/firms/3one4-capital
https://twitter.com/3one4capital
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=326447781
https://www.privateequityinternational.com/database/#/profile?id=18831

Nitya Agarwal

Vice President, Investment

Ayushi Garg

Vice President

Sonali Goel

Analyst

Pranav Pai

Founding Partner and Chief Investment Officer

Nandita Pai

Associate

Richard Pinto

Principal and Head of Portfolio Management and Finance

Anurag Ramdasan

Partner

Sonal Saldanha

Vice President

Aman Soni

Associate

Ashwini Thulsaram

Principal and Head, Governance Business Integrity and Closure (GBIC)

Past deals in Chemical

Scimplifi

Series B in 2025
Scimplifi operates as a business-to-business fulfillment platform that focuses on sourcing and manufacturing specialty chemicals. The company utilizes a science-driven approach, featuring in-house teams dedicated to value engineering, chemical processes, and analytical research. Its technology-enabled platform enhances transparency and simplifies navigation throughout the supply chain, allowing businesses to effectively manage their chemical requirements. Scimplifi serves various industries, including pharmaceuticals, personal care, and agrochemicals, by providing tailored solutions that address their unique needs.

Scimplifi

Series A in 2024
Scimplifi operates as a business-to-business fulfillment platform that focuses on sourcing and manufacturing specialty chemicals. The company utilizes a science-driven approach, featuring in-house teams dedicated to value engineering, chemical processes, and analytical research. Its technology-enabled platform enhances transparency and simplifies navigation throughout the supply chain, allowing businesses to effectively manage their chemical requirements. Scimplifi serves various industries, including pharmaceuticals, personal care, and agrochemicals, by providing tailored solutions that address their unique needs.

Scimplifi

Seed Round in 2023
Scimplifi operates as a business-to-business fulfillment platform that focuses on sourcing and manufacturing specialty chemicals. The company utilizes a science-driven approach, featuring in-house teams dedicated to value engineering, chemical processes, and analytical research. Its technology-enabled platform enhances transparency and simplifies navigation throughout the supply chain, allowing businesses to effectively manage their chemical requirements. Scimplifi serves various industries, including pharmaceuticals, personal care, and agrochemicals, by providing tailored solutions that address their unique needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.